Quick Takeaways
- POPLAR POINT CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY).
- Disclosed ownership: 18%.
- Date of event: 15 Oct 2025.
Quoteable Key Fact
"POPLAR POINT CAPITAL MANAGEMENT LLC disclosed 18% ownership in Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY) on 15 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Poplar Point Capital Management LLC | 18% | 1,020,300 | 0 | 1,020,300 | /s/ Jad Fakry | Jad Fakhry, Manager | 0001588273 |
| Poplar Point Capital Partners LP | 18% | 1,020,300 | 0 | 1,020,300 | /s/ Jad Fakry | Jad Fakhry, Manager | 0001588289 |
| Poplar Point Capital GP LLC | 18% | 1,020,300 | 0 | 1,020,300 | /s/ Jad Fakry | Jad Fakhry, Manager | 0001588288 |
| Jad Fakhry | 18% | 1,020,300 | 0 | 1,020,300 | /s/ Jad Fakry | Jad Fakhry | 0001588217 |